Flexibilization of Infliximab Dose Interval in the Treatment of Ankylosing Spondylitis
AuthID
P-004-8X3
P-004-8X3
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service